Non-Invasive Hemoglobin Monitoring of Women Undergoing Cesarean Delivery
Overview
- Phase
- Not Applicable
- Intervention
- Not specified
- Conditions
- Complications of Pregnancy, Childbirth and the Puerperium
- Sponsor
- Stony Brook University
- Enrollment
- 50
- Locations
- 1
- Primary Endpoint
- Decrease in Hemoglobin over time
- Status
- Completed
- Last Updated
- last year
Overview
Brief Summary
The purpose of this study is to determine the normal hemoglobin curve during cesarean delivery and for the first 24 hours after surgery to aid in the creation of an algorithm to detect life-threatening bleeding earlier.
Detailed Description
Acute and life threatening blood loss is the most common cause of morbidity and mortality for pregnancy women in the US. To date, the only means we have of monitoring the amount of blood loss during a delivery is by the physician estimating the amount. This has been shown to not be very accurate and leads to confusion on when and how much a women should be transfused during a hemorrhage. New devices have been developed over the last few years to monitor blood levels in a accurate and non-invasive fashion. We aim here to use a non-invasive blood monitoring system to evaluate normal blood loss in women undergoing scheduled cesarean delivery. We hope that this will allow us to create a baseline that can be used in subsequent studies to identify women who are losing more blood than normal so that we may intervene faster and avoid unnecessary morbidity.
Investigators
Joseph Chappelle
Assistant Professor
Stony Brook University
Eligibility Criteria
Inclusion Criteria
- •Women undergoing scheduled cesarean delivery
Exclusion Criteria
- •Blood disorders (i.e. thalassemia, sickle cell), hypertensive disorders, obstetric risk factors for hemorrhage
Outcomes
Primary Outcomes
Decrease in Hemoglobin over time
Time Frame: 24 hours